Giuseppe Filardo1, Luca Andriolo2, Federica Balboni3, Maurilio Marcacci4, Elizaveta Kon5. 1. II Clinic - Biomechanics Laboratory, Rizzoli Orthopaedic Institute, Via Di Barbiano, 1/10, 40136, Bologna, Italy. g.filardo@biomec.ior.it. 2. II Clinic - Biomechanics Laboratory, Rizzoli Orthopaedic Institute, Via Di Barbiano, 1/10, 40136, Bologna, Italy. lucas.andriolo@gmail.com. 3. II Clinic - Biomechanics Laboratory, Rizzoli Orthopaedic Institute, Via Di Barbiano, 1/10, 40136, Bologna, Italy. balboni.federica@gmail.com. 4. II Clinic - Biomechanics Laboratory, Rizzoli Orthopaedic Institute, Via Di Barbiano, 1/10, 40136, Bologna, Italy. m.marcacci@biomec.ior.it. 5. II Clinic - Biomechanics Laboratory, Rizzoli Orthopaedic Institute, Via Di Barbiano, 1/10, 40136, Bologna, Italy. e.kon@biomec.ior.it.
Abstract
PURPOSE: While midterm results of matrix-assisted autologous chondrocyte transplantation (MACT) are now available, less attention has been paid to the evaluation of failures of this surgical approach. Aim of this study was to analyse how "failures" are generally defined in cartilage surgery, in order to understand how the survival rate may change according to different definitions of failure. METHODS: A systematic review on MACT in the knee was conducted to report failure rates as well as different failure definitions in the available literature. Afterwards, we analysed the survival curve at 8.5-year follow-up of a survey of 193 patients treated with MACT. Using different definitions to identify failures, we compared how the survival rate changed according to the different definitions of failure. RESULTS: The systematic review on 93 papers showed that the average failure rate reported on 3,289 patients was 5.2 % at a mean 34 months of follow-up. However, 41 studies (44.1 %) did not even consider this aspect, and failures were variously defined, thus generating confusing data that make a meta-analysis or a study comparison meaningless. The failure analysis of the MACT survey showed that the survival curve changed significantly depending on the definition applied; in fact, the failure rate ranged from 3.6 to 33.7 %. According to a critical literature and survey analysis, we proposed a combined surgical- and improvement-based definition which led to a failure rate of 25.9 % at midterm/long-term follow-up. CONCLUSION: Nowadays, failure definitions of cartilage treatments differ in scientific articles, thus generating confusion and heterogeneous data even when applied to the same cohort of patients. While the literature analysis shows a low number of failures, this study demonstrated that if properly addressed with a comprehensive definition, the real failure rate of cartilage surgical procedures in the knee is higher than previously reported. Recognizing failures would give a better understanding and a more realistic prognosis to patients and physicians seeking treatment for cartilage lesions. LEVEL OF EVIDENCE: IV.
PURPOSE: While midterm results of matrix-assisted autologous chondrocyte transplantation (MACT) are now available, less attention has been paid to the evaluation of failures of this surgical approach. Aim of this study was to analyse how "failures" are generally defined in cartilage surgery, in order to understand how the survival rate may change according to different definitions of failure. METHODS: A systematic review on MACT in the knee was conducted to report failure rates as well as different failure definitions in the available literature. Afterwards, we analysed the survival curve at 8.5-year follow-up of a survey of 193 patients treated with MACT. Using different definitions to identify failures, we compared how the survival rate changed according to the different definitions of failure. RESULTS: The systematic review on 93 papers showed that the average failure rate reported on 3,289 patients was 5.2 % at a mean 34 months of follow-up. However, 41 studies (44.1 %) did not even consider this aspect, and failures were variously defined, thus generating confusing data that make a meta-analysis or a study comparison meaningless. The failure analysis of the MACT survey showed that the survival curve changed significantly depending on the definition applied; in fact, the failure rate ranged from 3.6 to 33.7 %. According to a critical literature and survey analysis, we proposed a combined surgical- and improvement-based definition which led to a failure rate of 25.9 % at midterm/long-term follow-up. CONCLUSION: Nowadays, failure definitions of cartilage treatments differ in scientific articles, thus generating confusion and heterogeneous data even when applied to the same cohort of patients. While the literature analysis shows a low number of failures, this study demonstrated that if properly addressed with a comprehensive definition, the real failure rate of cartilage surgical procedures in the knee is higher than previously reported. Recognizing failures would give a better understanding and a more realistic prognosis to patients and physicians seeking treatment for cartilage lesions. LEVEL OF EVIDENCE: IV.
Authors: Philipp Niemeyer; Jan M Pestka; Peter C Kreuz; Christoph Erggelet; Hagen Schmal; Norbert P Suedkamp; Matthias Steinwachs Journal: Am J Sports Med Date: 2008-09-18 Impact factor: 6.202
Authors: Jay R Ebert; Anne Smith; Peter K Edwards; Karen Hambly; David J Wood; Timothy R Ackland Journal: Am J Sports Med Date: 2013-04-25 Impact factor: 6.202
Authors: Giuseppe Filardo; Francesca Vannini; Maurilio Marcacci; Luca Andriolo; Alberto Ferruzzi; Sandro Giannini; Elizaveta Kon Journal: Am J Sports Med Date: 2012-10-25 Impact factor: 6.202
Authors: H Tohyama; K Yasuda; A Minami; T Majima; N Iwasaki; T Muneta; I Sekiya; K Yagishita; S Takahashi; K Kurokouchi; Y Uchio; J Iwasa; M Deie; N Adachi; K Sugawara; M Ochi Journal: J Orthop Sci Date: 2009-10-03 Impact factor: 1.601
Authors: Peter C Kreuz; Sebastian Müller; Christoph Erggelet; Arvind von Keudell; Thomas Tischer; Christian Kaps; Philipp Niemeyer; Anja Hirschmüller Journal: Knee Surg Sports Traumatol Arthrosc Date: 2012-11-28 Impact factor: 4.342
Authors: G Filardo; S Zaffagnini; R De Filippis; F Perdisa; L Andriolo; C Candrian Journal: Knee Surg Sports Traumatol Arthrosc Date: 2018-02-16 Impact factor: 4.342
Authors: S Zaffagnini; F Vannini; A Di Martino; L Andriolo; A Sessa; F Perdisa; F Balboni; G Filardo Journal: Knee Surg Sports Traumatol Arthrosc Date: 2018-10-29 Impact factor: 4.342
Authors: Marcus Vinicius Danieli; João Paulo Fernandes Guerreiro; Alexandre Oliveira Queiroz; Hamilton da Rosa Pereira; Daniele Cristina Cataneo Journal: Int Orthop Date: 2020-09-29 Impact factor: 3.075
Authors: Francesco Perdisa; Natalia Gostyńska; Alice Roffi; Giuseppe Filardo; Maurilio Marcacci; Elizaveta Kon Journal: Stem Cells Int Date: 2015-07-09 Impact factor: 5.443
Authors: Elizaveta Kon; Giuseppe Filardo; Mats Brittberg; Maurizio Busacca; Vincenzo Condello; Lars Engebretsen; Stefan Marlovits; Philipp Niemeyer; Patrik Platzer; Michael Posthumus; Peter Verdonk; Renè Verdonk; Jan Victor; Willem van der Merwe; Wojciech Widuchowski; Claudio Zorzi; Maurilio Marcacci Journal: Knee Surg Sports Traumatol Arthrosc Date: 2017-09-14 Impact factor: 4.342